Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002701:Chloramphenicol / Q000494:pharmacology; D004269:DNA, Bacterial / Q000096:biosynthesis; D004926:Escherichia coli / Q000187:drug effects*; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D010093:Oxolinic Acid / Q000494:pharmacology; D012329:RNA, Bacterial / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D012329:RNA, Bacterial; D009268:Nalidixic Acid; D002701:Chloramphenicol; D010093:Oxolinic Acid; D012293:Rifampin